PPTC - Pediatric Preclinical Testing Consortium
Description: The PIVOT consortium collaborates with industry partners on preclinical testing of molecularly targeted agents developed for adult cancers to evaluate their applicability to the treatment of pediatric cancer. Contact Us to Discuss Pediatric Preclinical Testing for Your Molecularly Targeted Agent The Pediatric Preclinical In Vivo Testing (PIVOT) consortium comprises a coordinating center and seven academic…
Advancing treatment options for children with cancer
The P ediatric Preclinical I n Vi vo T esting (PIVOT) consortium comprises a coordinating center and seven academic research programs specializing in basic research and preclinical testing of treatments for the most common pediatric cancers. Our team has decades of experience with the development, characterization and testing of in vivo models of pediatric cancer. PIVOT is a public-private partnership funded by the National Cancer Institute (NCI).
Carol J. Bult, PhD Jeff H. Chuang, PhD Emily Jocoy, PhD Dennis Dean, PhD
PPTC - Pediatric Preclinical Testing Consortium